Dr. Jocelyn A. Rowe, MD

Dr. Rowe practices at Mount Sinai Hospital in Chicago, Illinois, part of Sinai Health System.

Dr. Rowe's NPI, 1902023864, was assigned on April 19, 2007. Dr. Rowe holds Illinois license 036123604.

Dr. Rowe's primary practice is Mount Sinai Hospital, at 15th Street at California, Chicago, IL 60608 in Cook County. The practice phone is (773) 542-2000. Dr. Rowe also practices at Mount Sinai Hospital Medical Center, 1500 S Fairfield Ave, Chicago, IL 60608.

Dr. Rowe's primary practice is Mount Sinai Hospital in Chicago, Illinois, part of Sinai Health System. The medical group on file is John H. Stroger, Jr. Hospital of Cook County. Dmand AI also links Dr. Rowe to 3 more medical groups, 1 breast imaging center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rowe practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Rowe's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Rowe is licensed in Illinois.

CMS data shows 204 Medicare services from Dr. Rowe across 5 procedure codes in 2024, for 150 Medicare patients. Medicare paid $10,762 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 150 Medicare patients who saw Dr. Rowe in 2024. The largest group is 65 to 74, with 72 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 71% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rowe's median patient age at 71, with 59% women.

In 2024, Dr. Rowe wrote 944 Medicare Part D claims for 215 patients. 69% of them were for generic drugs. CMS names the drug for 913 of them, across 14 drugs with 11 or more claims each, at $28,254 in total drug cost. In 2023, CMS named 843 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Rowe for performance year 2024, reported as part of a group. Dr. Rowe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 40 procedures of cataract surgery by Dr. Rowe, more than 59% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Rowe. Dr. Rowe has published most often in Arch Ophthalmol. Dr. Rowe's most frequent co-authors are Sarah M. Nehls, MD, Daniel M. Albert, MD and Christopher R. Croasdale, MD.

CMS Open Payments shows 18 general payments to Dr. Rowe from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Alcon Laboratories Inc paid the most, $214.